Anti-Inflammatory Activity
- Drug Discovery & Preclinical
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Vaccines (Prophylactic & Therapeutic)
- Cell & Gene Therapies (CGT)
- Allergy & Hypersensitivity
- Biomarker
- High-Dimensional Single-Cell Analysis by Flow Cytometry
- High-Throughput Cytokine & Chemokine Profiling by Multiplexing
- Biomarkers via Advanced IHC & Spatial Imaging
- Rare Cellular Functional Biomarkers by ELISPOT
- Real-Time Kinetic Biomarkers by IncuCyte S3
- Genomic Biomarker Analysis by qPCR & Droplet Digital PCR
- Seahorse XF: Immunometabolism & Bioenergetics
- MALDI Biotyper: Rapid Microbial & Proteomic Profiling
- Sapidyne KinExA
- Robust Protein Quantification by ELISA
- Advanced LNP Formulation & Screening – Unchained Labs Sunshine
- Translational & Clinical Research
- Immunogenicity Risk Assessment & Immunotoxicology
- Regulated Bioanalysis: PK, PD & Soluble Biomarkers
- Histopathology & Spatial Biology
- Advanced Flow Cytometry & Cellular Immunology
- Molecular Bioanalysis & Genomic Profiling
- Functional Potency & Ex Vivo Translational Models
- Central Laboratory & Clinical Trial Sample Management
- Dermo-Cosmetics & FMCG
- Nutraceuticals & Wellness
- Biorepository
Anti-Inflammatory Activity
We evaluate inflammatory modulation using pathway-driven and cytokine-based models to provide a multi-layered understanding of how your product reduces inflammation:
- Evaluating inflammatory modulation through NF-κB signaling
- Comprehensive cytokine profiling (TNF-α, IL-6, IL-1β)
- Targeted enzyme inhibition analysis (COX-2, 5-LOX).